Eli Lilly, Novartis back a $26M round for Cavion’s work on neurological diseases
The corporate venture arms of Eli Lilly and Novartis are backing a $26.1 million round for Charlottesville, VA-based Cavion, a startup focused on a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.